Query String: DOCETAXEL
BDBM36351 CID148124 Docetaxel
- Buchholz, S; Schally, AV; Engel, JB; Hohla, F; Heinrich, E; Koester, F; Varga, JL; Halmos, G Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel. Proc Natl Acad Sci U S A 104: 1943-6 (2007)
- Cui, J; Meng, Q; Zhang, X; Cui, Q; Zhou, W; Li, S Design and Synthesis of Newa-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression. J Med Chem 58: 3534-47 (2015)
- ChEMBL_968413 Inhibition of p-gp in human KB/VCR cells assessed as potentiation of 100 nM docetaxel-induced cytotoxicity after 72 hrs by MTT assay
- ChEMBL_1474535 Inhibition of CYP1B1 in TCDD-stimulated human MCF7 cells assessed as inhibition of anticancer drug resistance by measuring docetaxel cytotoxic IC50 at 5 uM after 48 hrs by MTT assay (Rvb = 139.8 +/- 11.5 microM)
- ChEMBL_1474536 Inhibition of CYP1B1 in TCDD-stimulated human MCF7 cells assessed as inhibition of anticancer drug resistance by measuring docetaxel cytotoxic IC50 at 10 uM after 48 hrs by MTT assay (Rvb = 139.8 +/- 11.5 microM)